These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 22925316

  • 1. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
    Altenburg J, de Graaff CS, van der Werf TS, Boersma WG.
    Respiration; 2011 Sep; 81(1):75-87. PubMed ID: 20733282
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Macrolides and airway inflammation in children.
    Shinkai M, Rubin BK.
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [Abstract] [Full Text] [Related]

  • 7. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P, Fabbri LM, Bush A.
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [Abstract] [Full Text] [Related]

  • 8. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS, Rubin BK.
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [Abstract] [Full Text] [Related]

  • 9. [Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases].
    Sacre Hazouri JA.
    Rev Alerg Mex; 2006 Jun; 53(3):108-22. PubMed ID: 16970113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE, Rubin BK.
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Usefulness of macrolides as anti-inflammatories in respiratory diseases].
    Sevilla-Sánchez D, Soy-Muner D, Soler-Porcar N.
    Arch Bronconeumol; 2010 May; 46(5):244-54. PubMed ID: 19962815
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibiotics as immunomodulant agents in COPD.
    Blasi F, Mantero M, Aliberti S.
    Curr Opin Pharmacol; 2012 Jun; 12(3):293-9. PubMed ID: 22321568
    [Abstract] [Full Text] [Related]

  • 18. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R.
    J Med Chem; 2012 Jul 12; 55(13):6111-23. PubMed ID: 22697905
    [Abstract] [Full Text] [Related]

  • 19. The role of atypical infections and macrolide therapy in patients with asthma.
    Rollins DR, Good JT, Martin RJ.
    J Allergy Clin Immunol Pract; 2014 Jul 12; 2(5):511-7. PubMed ID: 25213043
    [Abstract] [Full Text] [Related]

  • 20. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S, Egan JJ.
    Expert Rev Anti Infect Ther; 2005 Dec 12; 3(6):923-30. PubMed ID: 16307505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.